Marinna is a co-founder and Chief Product Officer at Cellino, a venture capital-backed biotech company building a biomanufacturing platform to scale production of personalized induced pluripotent stem cell (iPSC)-based therapies. She received her PhD and MA in Applied Physics from Harvard University, where she co-invented laser-based intracellular delivery techniques. She received her BSc in Biophysics from University of California, Los Angeles, after transferring from Riverside Community College. She is the recipient of the Harvard Graduate Prize Fellowship, the Catalyst Accelerator Grant from Harvard Medical School, and is on the Forbes 30 Under 30 2019 list for Healthcare. She has several patents, peer-reviewed publications, and wrote the first review paper on autologous iPSC-based cell therapies. She is also passionate about access to education and the role the community college system plays in providing upward mobility for historically disadvantaged groups.